Location History:
- Rome, IT (2015 - 2016)
- Rocca Di Papa, IT (2014 - 2019)
Company Filing History:
3 out of 135 
1 out of 2,943 
1 out of 145 
Years Active: 2014-2019
Title: Rita Agostinetto: Innovator in Pharmaceutical Formulations
Introduction
Rita Agostinetto is a prominent inventor based in Rocca di Papa, Italy. She has made significant contributions to the field of pharmaceutical formulations, particularly focusing on innovative compositions that enhance medical procedures. With a total of 5 patents to her name, Agostinetto's work is recognized for its potential impact on reproductive health and stability of pharmaceutical products.
Latest Patents
One of her latest patents is a topical liquid composition comprising melatonin. This invention relates to a novel melatonin-based formulation, particularly suitable for use in intrauterine washing during medically assisted reproduction, such as in vitro fertilization (IVF). The compositions exhibit high stability, allowing them to be stored for prolonged periods before use in preventing embryonic implantation failure. Another significant patent involves liquid formulations of tumor necrosis factor-binding proteins. This invention presents a stable, pharmaceutically acceptable aqueous formulation that includes a TNF-binding protein, a buffer, and an isotonicity agent.
Career Highlights
Throughout her career, Rita Agostinetto has worked with notable companies, including Ares Trading S.a. and Merck Patent GmbH. Her experience in these organizations has contributed to her expertise in developing innovative pharmaceutical solutions.
Collaborations
Rita has collaborated with esteemed colleagues such as Fabrizio Samaritani and Alessandra Del Rio. These partnerships have fostered a collaborative environment that enhances the development of her groundbreaking inventions.
Conclusion
Rita Agostinetto's contributions to pharmaceutical formulations demonstrate her commitment to innovation in the medical field. Her patents reflect a deep understanding of the challenges in reproductive health and the need for stable pharmaceutical products. Through her work, Agostinetto continues to pave the way for advancements in medical technology.